| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.33 | 0.1 |